BioInvent International (Sweden) Insiders
| BINV Stock | SEK 29.40 1.70 5.47% |
BioInvent International employs about 93 people. The company is managed by 9 executives with a total tenure of roughly 24 years, averaging almost 2.0 years of service per executive, having 10.33 employees per reported executive. Breaking down BioInvent International's management performance can provide insight into the firm performance.
| Martin Welschof CEO President CEO |
| Kristoffer Hansson President Vice President Technical Operations |
BioInvent |
BioInvent International Management Team Effectiveness
The company has return on total asset (ROA) of (0.0192) % which means that it has lost $0.0192 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0274) %, meaning that it generated substantial loss on money invested by shareholders. BioInvent International's management efficiency ratios could be used to measure how well BioInvent International manages its routine affairs as well as how well it operates its assets and liabilities.BioInvent International Workforce Comparison
BioInvent International AB is number one stock in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 344. BioInvent International totals roughly 93.0 in number of employees claiming about 27% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.14) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.16) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.16. BioInvent International Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. BioInvent International Price Series Summation is a cross summation of BioInvent International price series and its benchmark/peer.
BioInvent International Notable Stakeholders
A BioInvent International stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as BioInvent International often face trade-offs trying to please all of them. BioInvent International's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting BioInvent International's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Martin Welschof | President CEO | Profile | |
| Kristoffer Hansson | Vice President Technical Operations | Profile | |
| Andres McAllister | Chief Medical Officer | Profile | |
| Stefan MBA | Chief Officer | Profile | |
| Ingrid Teige | Head Research | Profile | |
| RGN MSc | Chief Officer | Profile | |
| Cecilia Hofvander | Director Relations | Profile | |
| Sylvie Ryckebusch | Chief Officer | Profile | |
| Bjrn Frendus | Chief Officer | Profile |
About BioInvent International Management Performance
The success or failure of an entity such as BioInvent International often depends on how effective the management is. BioInvent International management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of BioInvent management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the BioInvent management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
BioInvent International AB focuses on the research and development of immunomodulating antibodies for the treatment of cancer in Sweden, Europe, and internationally. The Company was founded in 1997 and is based in Lund, Sweden. BioInvent International operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 68 people.
Please note, the imprecision that can be found in BioInvent International's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of BioInvent International AB. Check BioInvent International's Beneish M Score to see the likelihood of BioInvent International's management manipulating its earnings.
BioInvent International Workforce Analysis
Traditionally, organizations such as BioInvent International use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare BioInvent International within its industry.BioInvent International Manpower Efficiency
Return on BioInvent International Manpower
| Revenue Per Employee | 208.4K | |
| Revenue Per Executive | 2.2M | |
| Net Loss Per Employee | 3M | |
| Net Loss Per Executive | 30.9M | |
| Working Capital Per Employee | 301.1K | |
| Working Capital Per Executive | 3.1M |
Additional Tools for BioInvent Stock Analysis
When running BioInvent International's price analysis, check to measure BioInvent International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioInvent International is operating at the current time. Most of BioInvent International's value examination focuses on studying past and present price action to predict the probability of BioInvent International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioInvent International's price. Additionally, you may evaluate how the addition of BioInvent International to your portfolios can decrease your overall portfolio volatility.